Literature DB >> 27919913

When the price is right: drug costing and NICE approval.

Nigel Hawkes1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27919913     DOI： 10.1136/bmj.i6519

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Responsible pricing in value-based assessment of cancer drugs: real-world data are an inevitable addition to select meaningful new cancer treatments.

Authors:  Wim van Harten; Maarten J IJzerman
Journal:  Ecancermedicalscience       Date:  2017-09-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.